DATA ON ABUSE POTENTIAL OF PITOLISANT PRESENTED AT 2018 ESRS CONGRESS
Know more
News
HARMONY BIOSCIENCES PRESENTS 5-YEAR DATA ON PITOLISANT AT INTERNATIONAL NARCOLEPSY SYMPOSIUM
Know more
Bioprojet and Endo Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Pitolisant in Canada
Know more
Bioprojet will be taking part in the ESRS Congress in Basel, from the 25th to the 29th September.
Know more
Bioprojet at the 47th Annual meeting Histamine Research Society
Know more
Bioprojet: Pitolisant Progresses Towards the U.S. Market
Know more
AOP Orphan will distribute Wakix® (pitolisant) from Bioprojet Pharma in Austria, Nordic countries and Central Eastern Europe
Know more
Harmony biosciences acquires us rights to pitolisant from bioprojet; raises $270 million in equity financing
Know more